James River Asset Management LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Sell
1,175
-7
-0.6% -$1.8K 0.19% 65
2026
Q2
$297K Buy
1,182
+106
+10% +$22.8K 0.19% 68
2026
Q1
$234K Buy
1,076
+8
+0.7% +$1.78K 0.17% 76
2025
Q4
$244K Buy
+1,068
New +$243K 0.18% 63

Other funds holding ABBV

James River Asset Management LLC's ABBV Position: Q3 2026 in Review

James River Asset Management LLC reduced its AbbVie (ABBV) stake by 0.59% in Q3 2026, selling an estimated $1.8K and leaving 1,175 shares worth $307K. The position accounts for 0.19% of the portfolio, ranked #65.

James River Asset Management LLC first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,161 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • James River Asset Management LLC held 1,175 shares of AbbVie worth $307K as of Q3 2026.
  • James River Asset Management LLC sold 7 AbbVie shares in Q3 2026, an estimated $1.8K.
  • AbbVie made up 0.19% of James River Asset Management LLC's portfolio in Q3 2026, its #65 holding.
  • James River Asset Management LLC first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,161 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on James River Asset Management LLC's 13F filing for Q3 2026, filed 16 Nov 2026.